Cargando…
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management
SIMPLE SUMMARY: Liquid biopsy is a minimally invasive method that emerged as a new promising tool for improving diagnosis, risk stratification, follow-up, and treatment of cancer patients. To date, the majority of the research in the area of liquid biopsy has focused on plasma-based cell-free DNA as...
Autores principales: | Marotta, Vincenzo, Cennamo, Michele, La Civita, Evelina, Vitale, Mario, Terracciano, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654679/ https://www.ncbi.nlm.nih.gov/pubmed/36358788 http://dx.doi.org/10.3390/cancers14215370 |
Ejemplares similares
-
Comparison between a new thyroglobulin assay with the well‐established Beckman Access immunoassay: A preliminary report
por: Cennamo, Michele, et al.
Publicado: (2020) -
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
por: Ottaviano, Margaret, et al.
Publicado: (2021) -
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model
por: Gentile, Francesco, et al.
Publicado: (2021) -
Reply to Jue et al. Value of MRI to Improve Deep Learning Model That Identifies High-Grade Prostate Cancer. Comment on “Gentile et al. Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model. Diagnostics 2021, 11, 335”
por: Gentile, Francesco, et al.
Publicado: (2021) -
Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers
por: Tortora, Fabiana, et al.
Publicado: (2023)